Clinical Trial 41898


Winter Haven, FL 33880

Study Summary:

To evaluate the efficacy, safety and tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the acute treatment of a migraine.

Qualified Participants Must:

• Be at least 18 years of age
• Experience at least 2 migraines per month over the last 6 months

Qualified Participants May Receive:

- Study related procedures such as blood work and ECG

- Compensation for time and travel expenses

- Physical performed by a board certified physician

Study is Available At:

Clinical Research of Central Florida
500 East Central Ave
Winter Haven, FL 33880
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 25 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.